We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

600483:SSEFujian Funeng Co., Ltd. Class A Analysis

Data as of 2026-06-12 - not real-time

CN¥11.64

Latest Price

5/10Risk

Risk Level: Medium

Executive Summary

Fujian Funeng Co., Ltd. (600483.SS) is trading at a price (≈CNY 11.64) that sits comfortably above its 20‑day simple moving average (≈CNY 11.34) and just above the calculated support level (≈CNY 10.40), while remaining below the near‑term resistance (≈CNY 12.14).
The technical picture is reinforced by a bullish MACD histogram (+0.01) and an RSI of 58.8, suggesting continued upward momentum in the short run. The stock’s valuation appears attractive: its trailing P/E of roughly 12 is well below the industry average of about 20, and the price‑to‑book ratio of 1.17 signals a modest premium to net assets.
Dividend sustainability is strong, with a 3.27% yield backed by a low payout ratio (≈38 %), and the balance sheet, despite a high debt‑to‑equity of ~62, shows ample cash (≈CNY 10.2 bn) and operating cash flow (≈CNY 4.8 bn). Combined with a low beta (~0.20) and a volatility of ~30 % over 30 days, the equity offers defensive characteristics typical of the Utilities‑Diversified sector while still providing upside potential from its bullish technical signals.

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 7/10

Key Factors

  • Bullish MACD histogram and RSI indicating upward momentum
  • Price above 20‑day SMA and near support level
  • Attractive dividend yield with low payout ratio

Medium Term

1–3 years
Neutral
Model confidence: 5/10

Key Factors

  • Undervalued P/E relative to sector peers
  • Low beta and defensive utilities exposure
  • Sustainable dividend despite modest free cash flow

Long Term

> 3 years
Positive
Model confidence: 8/10

Key Factors

  • Strong balance sheet and ample cash reserves
  • Defensive sector positioning with stable earnings
  • Long‑term dividend sustainability and value‑oriented pricing

Key Metrics & Analysis

Financial Health

Revenue Growth-5.20%
Profit Margin21.01%
P/E Ratio11.8
ROE10.33%
ROA3.57%
Debt/Equity61.80
P/B Ratio1.2
Op. Cash FlowCN¥4.8B
Free Cash FlowCN¥-583856704
Industry P/E20.3

Technical Analysis

TrendBullish
RSI58.8
SupportCN¥10.40
ResistanceCN¥12.14
MA 20CN¥11.34
MA 50CN¥10.65
MA 200CN¥10.09
MACDBullish
VolumeStable
Fear & Greed Index86.71

Valuation

Fair ValueCN¥11.72
GradeUndervalued
TypeValue
Dividend Yield3.27%

Risk Assessment

Beta0.23
Volatility30.56%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.